33529 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Oct 13
00:11 UTC
|
MIRM
Mirum Pharmaceuticals
|
◎ Target | Yigal Nochomovitz ★★☆☆☆ #2785 | Buy | $160.00→ $184.00+15.0% |
|
Oct 13
00:11 UTC
|
MGM
MGM Resorts International
|
◎ Target | James Hardiman ★★☆☆☆ #2771 | Neutral | $48.00→ $32.00-33.3% |
|
Oct 13
00:11 UTC
|
MGA
Magna International
|
◎ Target | Tom Narayan ★★★☆☆ #1639 | Sec→ r Perform | $69.00→ $68.00-1.4% |
|
Oct 13
00:11 UTC
|
META
Meta Platforms
|
◎ Target | Deepak Mathivanan ★★★☆☆ #1948 | Overweight | $860.00→ $840.00-2.3% |
|
Oct 13
00:11 UTC
|
MET
MetLife
|
◎ Target | Wesley Carmichael ★★★★☆ #858 | Overweight | $109.00→ $110.00+0.9% |
|
Oct 13
00:11 UTC
|
MELI
MercadoLibre
|
◎ Target | Deepak Mathivanan ★★★☆☆ #1948 | Overweight | $2,300.00→ $2,200.00-4.3% |
|
Oct 13
00:11 UTC
|
MDT
Medtronic
|
◎ Target | Ryan Zimmerman ★★☆☆☆ #2482 | Buy | $100.00→ $99.00-1.0% |
|
Oct 13
00:11 UTC
|
MBX
MBX Biosciences
|
◎ Target | Annabel Samimy ★☆☆☆☆ #3079 | Buy | $70.00→ $84.00+20.0% |
|
Oct 13
00:11 UTC
|
MAR
Marriott International
|
◎ Target | Stephen Grambling ★★★☆☆ #1657 | Overweight | $380.00→ $384.00+1.1% |
|
Oct 13
00:11 UTC
|
MAIR
Madison Air Solutions
|
◎ Target | Andrew Kaplowitz ★★★☆☆ #2164 | Buy | $49.00→ $40.00-18.4% |
|
Oct 13
00:11 UTC
|
MAC
Macerich
|
◎ Target | Alexander Goldfarb ★★★☆☆ #1807 | Overweight | $30.00→ $26.00-13.3% |
|
Oct 13
00:11 UTC
|
MAA
Mid-America Apartment Communities
|
◎ Target | Alexander Goldfarb ★★★☆☆ #1807 | Neutral | $140.00→ $121.00-13.6% |
|
Oct 13
00:11 UTC
|
LPX
Louisiana-Pacific
|
◎ Target | Susan Maklari ★★★☆☆ #1961 | Sell | $74.00→ $64.00-13.5% |
|
Oct 13
00:11 UTC
|
LPLA
LPL Financial
|
◎ Target | Bill Katz not yet tracked | Hold | $377.00→ $380.00+0.8% |
|
Oct 13
00:11 UTC
|
LNC
Lincoln National
|
◎ Target | Wesley Carmichael ★★★★☆ #858 | Overweight | $52.00→ $54.00+3.8% |
|
Oct 13
00:11 UTC
|
LINE
Lineage
|
◎ Target | Alexander Goldfarb ★★★☆☆ #1807 | Neutral | $44.00→ $36.00-18.2% |
|
Oct 13
00:11 UTC
|
LIFE
Ethos Technologies Inc. Class A Common Stock
|
◎ Target | Matthew Carletti ★★★☆☆ #1122 | Market Outperform | $33.00→ $40.00+21.2% |
|
Oct 13
00:11 UTC
|
LHX
L3Harris Technologies
|
◎ Target | Noah Poponak ★☆☆☆☆ #2955 | Buy | $405.00→ $361.00-10.9% |
|
Oct 13
00:11 UTC
|
LEA
Lear
|
◎ Target | Tom Narayan ★★★☆☆ #1639 | Sec→ r Perform | $143.00→ $139.00-2.8% |
|
Oct 13
00:11 UTC
|
LCID
Lucid Group
|
◎ Target | Tom Narayan ★★★☆☆ #1639 | Sec→ r Perform | $7.00→ $4.00-42.9% |
|
Oct 13
00:11 UTC
|
KTOS
Kratos Defense & Security Solutions
|
◎ Target | Noah Poponak ★☆☆☆☆ #2955 | Buy | $88.00→ $77.00-12.5% |
|
Oct 13
00:11 UTC
|
KOD
Kodiak Sciences
|
◎ Target | Matthew Caufield ★★☆☆☆ #2492 | Buy | $96.00→ $126.00+31.2% |
|
Oct 13
00:11 UTC
|
KNSL
Kinsale Capital Group
|
◎ Target | Hristian Getsov ★★★★☆ #612 | Equal Weight | $377.00→ $348.00-7.7% |
|
Oct 13
00:11 UTC
|
KKR
KKR & Co. Inc.
|
◎ Target | Bill Katz not yet tracked | Hold | $118.00→ $103.00-12.7% |
|
Oct 13
00:11 UTC
|
KIM
Kimco Realty
|
◎ Target | Alexander Goldfarb ★★★☆☆ #1807 | Overweight | $31.00→ $27.00-12.9% |
|
Oct 13
00:11 UTC
|
JSG
Johnson Service Group
|
◎ Target | firm only | Buy | GBX 210→ GBX 200-4.8% |
|
Oct 13
00:11 UTC
|
JCI
Johnson Controls International
|
◎ Target | Andrew Kaplowitz ★★★☆☆ #2164 | Neutral | $157.00→ $170.00+8.3% |
|
Oct 13
00:11 UTC
|
IVZ
Invesco
|
◎ Target | Bill Katz not yet tracked | Buy | $39.00→ $38.00-2.6% |
|
Oct 13
00:11 UTC
|
ISRG
Intuitive Surgical
|
◎ Target | Ryan Zimmerman ★★☆☆☆ #2482 | Buy | $469.00→ $454.00-3.2% |
|
Oct 13
00:11 UTC
|
IP
International Paper
|
◎ Target | Michael Roxland ★★★☆☆ #1230 | Buy | $49.00→ $41.00-16.3% |
|
Oct 13
00:11 UTC
|
INVH
Invitation Home
|
◎ Target | Michael Goldsmith ★★★☆☆ #2233 | Buy | $35.00→ $31.00-11.4% |
|
Oct 13
00:11 UTC
|
INTA
Intapp
|
◎ Target | Saket Kalia ★★★★★ #124 | Underweight | $29.00→ $38.00+31.0% |
|
Oct 13
00:11 UTC
|
INIO
Innio
|
◎ Target | Andrew Kaplowitz ★★★☆☆ #2164 | Neutral | $30.00→ $22.00-26.7% |
|
Oct 13
00:11 UTC
|
IIPR
Innovative Industrial Properties
|
◎ Target | Alexander Goldfarb ★★★☆☆ #1807 | Underweight | $51.00→ $44.00-13.7% |
|
Oct 13
00:11 UTC
|
ICG
Intermediate Capital Group
|
◎ Target | firm only | Buy | GBX 2,800→ GBX 2,700-3.6% |
|
Oct 13
00:11 UTC
|
ICE
Intercontinental Exchange
|
◎ Target | Bill Katz not yet tracked | Hold | $166.00→ $167.00+0.6% |
|
Oct 13
00:11 UTC
|
IBP
Installed Building Products
|
◎ Target | Susan Maklari ★★★☆☆ #1961 | Buy | $297.00→ $257.00-13.5% |
|
Oct 13
00:11 UTC
|
HUM
Humana
|
◎ Target | Michael Wiederhorn ★★★★☆ #343 | Outperform | $475.00→ $525.00+10.5% |
|
Oct 13
00:11 UTC
|
HUM
Humana
|
◎ Target | A.J. Rice ★★★★☆ #702 | Neutral | $405.00→ $495.00+22.2% |
|
Oct 13
00:11 UTC
|
HUM
Humana
|
◎ Target | David MacDonald not yet tracked | Hold | $415.00→ $475.00+14.5% |
|
Oct 13
00:11 UTC
|
HST
Host Hotels & Resorts
|
◎ Target | Stephen Grambling ★★★☆☆ #1657 | Equal Weight | $22.00→ $24.00+9.1% |
|
Oct 13
00:11 UTC
|
HRI
Herc
|
◎ Target | Kyle Menges ★★☆☆☆ #2356 | Buy | $175.00→ $150.00-14.3% |
|
Oct 13
00:11 UTC
|
HP
Helmerich & Payne
|
◎ Target | Josh Silverstein ★★★☆☆ #1661 | Buy | $49.00→ $50.00+2.0% |
|
Oct 13
00:11 UTC
|
HP
Helmerich & Payne
|
◎ Target | Eddie Kim ★★★☆☆ #1307 | Overweight | $50.00→ $51.00+2.0% |
|
Oct 13
00:11 UTC
|
HON
Honeywell International
|
◎ Target | Andrew Kaplowitz ★★★☆☆ #2164 | Buy | $279.00→ $270.00-3.2% |
|
Oct 13
00:11 UTC
|
HNGE
Hinge Health
|
◎ Target | Saket Kalia ★★★★★ #124 | Overweight | $100.00→ $110.00+10.0% |
|
Oct 13
00:11 UTC
|
HLT
Hilton Worldwide
|
◎ Target | Stephen Grambling ★★★☆☆ #1657 | Overweight | $332.00→ $336.00+1.2% |
|
Oct 13
00:11 UTC
|
HIG
The Hartford Insurance Group
|
◎ Target | Elyse Greenspan ★★★☆☆ #1080 | Overweight | $164.00→ $158.00-3.7% |
|
Oct 13
00:11 UTC
|
HIG
The Hartford Insurance Group
|
◎ Target | Meyer Shields ★★★★☆ #400 | Market Perform | $144.00→ $137.00-4.9% |
|
Oct 13
00:11 UTC
|
HHH
Howard Hughes
|
◎ Target | Alexander Goldfarb ★★★☆☆ #1807 | Overweight | $100.00→ $83.00-17.0% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.